Prostate Cancer Awareness
According to the American Cancer Society, 1 man out of 9 will be diagnosed with prostate cancer and it is the second leading cause of cancer death among men. However, most men diagnosed with prostate cancer do not die from the disease. The Surveillance, Epidemiology, and End Results database, maintained by the National Cancer Institute, states that the five year survival rate for all stages of prostate cancer combined is 98%.
Risk factors for prostate cancer include:
- Family history
- Inherited gene mutations
Obesity, smoking, and sexually transmitted diseases, while linked to many health problems, are still being researched regarding a link to prostate cancer.
While prostate cancer can not be prevented, prostate cancer screenings can result in early detection. However, it’s unclear whether the benefit of routinely screening all men for prostate cancer outweigh the risks, including the side effects of unnecessary treatment. For this reason, it’s best to talk to your primary care provider about the uncertainties, risks, and potential benefits of a routine screening. Your doctor, who knows your personal and family history, can help you decide what is best for you.
You should discuss prostate cancer screening with your doctor if you are:
- Age 50 or older and at average risk of prostate cancer expected to live 10+ years.
- Age 45 or older and at high risk of developing prostate cancer. This includes African Americans and men who have a first-degree relative diagnosed with prostate cancer at an early age.
- Age 40 or older and have more than one first-degree relative who had prostate cancer at an early age.
If you and your doctor agree that a routine prostate cancer screening is right for you, come to Mercer Health Fall Fest for a free PSA blood test on October 19, 2019 from 8 – 11 a.m. Results will be mailed and we encourage you to share the results with your doctor. From there, the two of you can discuss the results and determine if a physical prostate exam is needed or if you should be evaluated by a urologist.